Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jun 13, 2022

50715_rns_2022-06-13_9fb9731a-90bc-43fa-ab75-208f9dbce810.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

13 June 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Descriptionof relevantsecurities Nature of dealings Purchase /Sale Totalnumberof sharesinvolved Total amountpaid / received Highest (H)prices paid/ received Lowest (L)prices paid/ received
CICC FinancialTrading Limited 10 June2022 Other typesof securities(e.g. equityswaps) Dealing in a derivative which isreferenced to a basket or indexincluding relevant securities whichrepresent less than 1% of the classin issue and less than 20% of thevalue of the securities in the basketor index Purchase 79,400 $3,389,550.0000 $42.6916 $42.6709
Ordinaryshares Hedging related to dealing inpre-existingindex-trackingETFs Sale 79,400 $3,389,231.5600 $42.8600 $42.7200

End

==> picture [71 x 43] intentionally omitted <==

Public Disclosure Form

Note:

CICC Financial Trading Limited is an exempt principal trader connected with the Offeror.

Dealings were made for its own account.

CICC Financial Trading Limited is ultimately owned by China International Capital Corporation Limited.

The shares reported refer to A shares of Yankuang Energy Group Company Limited (600188.SH), and price per unit is in RMB.